At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Prof Roy Herbst from Yale Cancer Center, Smilow Cancer Hospital at Yale-New Haven, New Haven, CT, explains that the recent development of immunotherapy and targeted therapies for lung cancer are offering great hope for patients.
Visit our website | [ Ссылка ]
Follow on Twitter | [ Ссылка ]
Like on Facebook | [ Ссылка ]
